paclitaxel and fk 866
paclitaxel has been researched along with fk 866 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bai, J; Chen, J; Jiang, S; Li, Z; Liao, C; Liu, Y; Qin, D; Qin, X; Qiu, Y; Tu, ZC | 1 |
| Chen, D; Jiang, S; Li, Z; Liao, C; Liu, Y; Ni, Y; Qiang, L; Qiu, Y; Tu, Z; Wang, D; Yao, Y; Zhang, K; Zhang, W | 1 |
Other Studies
2 other study(ies) available for paclitaxel and fk 866
| Article | Year |
|---|---|
Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Molecular Structure; Nicotinamide Phosphoribosyltransferase; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |